骨锚式助听生活质量系统综述:传导性与单侧感音神经性听力损失的比较
该系统综述检索多个数据库至2024年7月11日,纳入56篇文献,比较骨锚式助听植入(BAHI)使用者在单侧感音神经性听力损失(U-SNHL)与传导性/混合性听力损失(CHL)间的疾病特异性生活质量差异。结果显示APHAB的全局、EC、BN评分及GBI的全局、一般、生理评分在两组间存在显著差异,CHL患者在沟通便利性、声音清晰度及整体健康心理社会状态方面报告更大获益。
要点
- 共纳入56篇文献,使用8种疾病特异性生活质量量表。
- APHAB全局(p=0.0002)、EC(p<0.00001)、BN(p=0.02)评分在U-SNHL与CHL间有显著差异。
- GBI全局(p=0.0001)、一般(p=0.002)、生理(p=0.02)评分在两组间有显著差异。
核心结论
- BAHI使用者在U-SNHL与CHL间的疾病特异性生活质量存在差异,CHL患者在沟通便利性、声音清晰度及整体健康心理社会状态方面报告更大获益。
研究设计与样本
- 系统综述,检索Medline、Embase、CINAHL、Cochrane、Global Health、Web of Science、Africa Wide Information和Global Index Medicus,从建库至2022年10月23日,并于2023年11月9日和2024年7月11日更新检索,无语言限制,遵循PRISMA标准,由两名独立评审员在Rayyan中筛选,第三名评审员解决分歧,使用RoBANS评估偏倚风险。
主要发现
- 共使用8种不同的疾病特异性生活质量量表。
- APHAB的全局评分(p=0.0002)、EC评分(p<0.00001)和BN评分(p=0.02)在U-SNHL与CHL人群间有显著差异。
- GBI的全局评分(p=0.0001)、一般评分(p=0.002)和生理评分(p=0.02)在U-SNHL与CHL人群间有显著差异。
关键数值与推荐
- APHAB全局评分在U-SNHL与CHL间p=0.0002。
- APHAB EC评分在U-SNHL与CHL间p<0.00001。
- APHAB BN评分在U-SNHL与CHL间p=0.02。
- GBI全局评分在U-SNHL与CHL间p=0.0001。
- GBI一般评分在U-SNHL与CHL间p=0.002。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study was to systematically review the differences in disease-specific quality of life (QoL) benefits experienced by bone-anchored hearing implant (BAHI) users between those diagnosed with unilateral sensorineural hearing loss (U-SNHL) and those with conductive/mixed hearing loss (CHL). DATA SOURCES: Eligible studies were searched for in Medline (Ovid), Embase (Ovid), CINAHL (Ebsco), Cochrane (Wiley), Global Health (Ovid), Web of Science (Clarivate Analytics), Africa Wide Information (Ebsco) and Global Index Medicus (WHO) from inception to October 23, 2022. Updated searches were performed on November 9, 2023, and July 11, 2024. REVIEW METHODS: There were no restrictions on language. PRISMA standards were followed, and screening was conducted by two independent reviewers in Rayyan, with a third reviewer resolving conflicts. Risk of bias was assessed using RoBANS. Articles were included if patients were implanted with a BAHI and administered a validated, disease-specific QoL measure. RESULTS: One thousand, three hundred twelve articles were identified after duplicate removal, with 56 articles meeting the inclusion criteria. Eight different disease-specific QoL measures were administered. In all, the APHAB's "Global" (p = 0.0002), EC (p < 0.00001), and BN (p = 0.02) scores, as well as the GBI's "Global" (p = 0.0001), "General" (p = 0.002), and "Physical" (p = 0.02) scores were significantly different between U-SNHL and CHL populations. CONCLUSION: These results demonstrated disease-specific QoL differences between BAHI users with U-SNHL and CHL. Specifically, patients with CHL reported greater benefits in domains pertaining to communication ease, the clarity of sound, and their overall health and psychosocial status.
引用
- Théorêt K, Deng J, da Silva SD, et al. Systematic Review of Quality of Life in Bone Anchored Hearing: Conductive vs. Unilateral Sensorineural Hearing Loss. Laryngoscope. 2025. PMID: 40346847. doi:10.1002/lary.32229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。